Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells. (Record no. 1923646)

MARC details
000 -LEADER
fixed length control field 01343 a2200385 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250511212652.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199110s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0162-3109
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/0162-3109(91)90025-t
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name D'Atri, S
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19911028
245 00 - TITLE STATEMENT
Title Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Immunopharmacology
Date of publication, distribution, etc.
300 ## - PHYSICAL DESCRIPTION
Extent 199-210 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antigens, Neoplasm
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytotoxicity, Immunologic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HLA Antigens
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Killer Cells, Lymphokine-Activated
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Killer Cells, Natural
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lung Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Triazenes
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Cells, Cultured
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Marini, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tentori, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tricarico, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fuggetta, M P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bonmassar, E
773 0# - HOST ITEM ENTRY
Title Immunopharmacology
Related parts vol. 21
-- no. 3
-- p. 199-210
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/0162-3109(91)90025-t">https://doi.org/10.1016/0162-3109(91)90025-t</a>
Public note Available from publisher's website

No items available.